Long-Term Liabilities: The sum of all non-current liabilities.
Astellas Pharma Inc. (ALPMY) had Long-Term Liabilities of $3.48B for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$9.31B |
|
$2.27B |
|
$14.15B |
|
$23.46B |
|
$9.01B |
|
$2.18B |
|
|
Long-Term Liabilities |
$3.48B |
$12.50B |
|
$10.96B |
|
$1.08B |
|
$10.96B |
|
-- |
|
| Cash Flow Statement Financials | |
$1.92B |
|
$-205.36M |
|
$-1.06B |
|
$1.28B |
|
$1.95B |
|
$671.04M |
|
-- |
|
$-450.44M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|